Dr. Scott Morgan on meta-analysis evaluating prostate RT in mHSPC
“In our analysis, the highest ranked treatment strategy was the combination of standard of care systemic therapy, an AR pathway inhibitor, and prostate radiotherapy,” says Scott Morgan, MD, MSc, FRCPC.